Clinical trial
Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
NCT03164018 is registered in ClinicalTrials.gov with Genesis Pharma CNS & Specialty as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
- Lead sponsor
- Genesis Pharma CNS & Specialty
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 7, 2017
- Completion date
- December 15, 2018
- Enrollment
- 111 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.